Valuation: Aprogen Biologics Inc.

Market Cap 22.45B 16.92M 15.19M 14.02M 12.71M 23.76M 1.61B 24.06M 168M 66.76M 842M 63.51M 62.15M 2.67B P/E 2024
-0.79x
P/E 2025 -0.6x
Enterprise Value 200B 150M 135M 125M 113M 211M 14.29B 214M 1.49B 594M 7.49B 565M 553M 23.75B EV / Sales 2024
3.66x
EV / Sales 2025 3.82x
Free-Float
24.16%
Yield 2024 *
-
Yield 2025 -
1 day+0.58%
1 week-7.41%
Current month-5.65%
1 month-15.38%
3 months-33.48%
6 months-63.16%
Current year-82.18%
1 week 1,369
Extreme 1369
1,509
1 month 1,369
Extreme 1369
1,725
Current year 1,369
Extreme 1369
8,490
1 year 1,369
Extreme 1369
9,945
3 years 1,369
Extreme 1369
53,250
5 years 1,369
Extreme 1369
154,500
10 years 1,369
Extreme 1369
858,000
Manager TitleAgeSince
Chief Executive Officer 63 2023-10-12
Chief Executive Officer 70 2012-03-31
Sales & Marketing 62 -
Director TitleAgeSince
Director/Board Member 70 2012-03-31
Director/Board Member 65 2020-03-22
Director/Board Member 63 2023-10-12
Date Insider Type Main position Quantity % Market Cap. Importance
6/28/24 Exercice

Executive/Senior Manager

6,183 0.0046%
6/28/24 Expiration

Chief Executive Officer

21,884 0.0164%
6/28/24 Exercice 11,846 0.0089% -
Change 5-day change 1-year change 3-year change Capi.($)
+0.58%-7.41%-83.55%-97.19% 16.82M
+0.22%+3.35%+55.30%+125.65% 1,140B
+0.91%+5.89%+41.14%+80.36% 641B
-0.12%+1.31%+25.62%+97.24% 507B
+0.63%+4.97%+47.12%+68.18% 383B
+0.86%-1.26%+62.10%+34.36% 347B
+1.02%+3.69%+23.73%+51.35% 293B
-0.25%+3.40%+2.31%+23.38% 266B
+0.75%+5.41%+53.53%+66.09% 240B
+0.25%+3.93%+31.54%+102.65% 197B
Average +0.52%+2.26%+25.88%+55.21% 401.38B
Weighted average by Cap. +0.55%+2.98%+42.01%+84.56%

Financials

2024 2025
Net sales 67.38B 50.78M 45.58M 42.09M 38.16M 71.33M 4.82B 72.21M 505M 200M 2.53B 191M 187M 8.02B 73.23B 55.19M 49.53M 45.74M 41.48M 77.52M 5.24B 78.47M 548M 218M 2.75B 207M 203M 8.71B
Net income -105B -79.12M -71.01M -65.57M -59.46M -111M -7.52B -112M -786M -312M -3.94B -297M -291M -12.49B -170B -128M -115M -106M -96.48M -180M -12.19B -183M -1.28B -507M -6.39B -482M -472M -20.27B
Net Debt 116B 87.2M 78.27M 72.27M 65.53M 122M 8.28B 124M 866M 344M 4.34B 327M 320M 13.77B 177B 134M 120M 111M 100M 188M 12.68B 190M 1.33B 527M 6.65B 501M 491M 21.08B
Projected Income Statement - Annual - Aprogen Biologics Inc.
Logo Aprogen Biologics Inc.
Aprogen Biologics Inc, formerly Aprogen Pharmaceuticals Inc, is a Korea-based company principally engaged in the pharmaceutical business. The Company operates its business through two segments. The Medicine Business segment is engaged in the manufacture and sale of central nervous system drugs, autonomic agents, arteriosclerosis agents, metabolic agents, circulatory system drugs, biopharmaceuticals and others. The Segment is also engaged in the manufacture and sale of cosmetics such as skin moisturizers and others. The Gaming Business segment is engaged in the development and operation of role-playing games (RPGs).
Employees
262
Date Price Change Volume
26-10-26 ₩1,387.00 +0.58% 47,488
26-10-26 ₩1,379.00 -0.58% 98,417
26-10-23 ₩1,387.00 -1.49% 107,052
26-10-22 ₩1,408.00 -2.22% 115,788
26-10-21 ₩1,440.00 -1.50% 84,857
  1. Stock Market
  2. Stocks
  3. A003060 Stock